Skip to main content
OpenTrials
Completed

NCT Number: NCT00796952

Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients

Swallowing dysfunction after chemo-radiation is common, but there is no reliable evidence for how it should be managed. This pilot randomized controlled trial evaluated the relative benefit of a battery of isometric / isotonic exercises on the maintenance of muscle composition and function for swallowing in Head / Neck Cancer patients undergoing chemo-radiation therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Florida, Health Science Center

Gainesville, Florida, 32610, United States

About this study

Swallowing deficits resulting from oropharyngeal cancer and the ablative therapies used to control the disease are often devastating to the functional feeding outcome in these patients. Most patients will experience some degree of dysphagia along with nutritional decline. In particular, the swallowing outcome of those patients treated with external beam radiation is suggested to be poorer than those patients treated by surgical interventions alone. It has also been postulated that the formation of radiation-induced fibrotic tissue, along with the acute radiation effects (edema, mucositis, xerostomia) may act collectively to promote muscular disuse or atrophy, and the noted decline in swallowing function. We therefore suggest that a program of swallowing exercises may help facilitate and maintain muscle function in the oral cavity and pharynx during radiotherapy, thus preserving or supporting swallowing function in these patients.

This study will follow a randomized controlled trial design. Patients with confirmed head / neck cancer identified for planned radiotherapy will undergo a baseline evaluation including clinical and instrumental swallowing assessment, nutritional examination, and MRI prior to CRT. Subjects will then be randomized to one of three intervention arms representing control, placebo and intervention groups. Patients will be treated for 6 weeks and progress reassessed at 6 months. Outcome assessment will be completed by a blinded observer. Primary outcomes include; I)Oropharyngeal active muscle volume, signal intensity, and tissue composition over time as identified by T2 weighted MRI, II)Level of functional swallowing ability,III)Patient perception of swallowing function and quality of life.The results of the study will provide information on the efficacy (or lack of efficacy) of isometric / isotonic exercises for the maintenance of swallowing function post radiotherapy for Head /Neck cancer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Head / neck cancer of the oropharyngeal or adjacent regions, confirmed by clinical history and exam, with positive cross sectional imaging studies and histopathological biopsy excluding other pathology.
  • Planned to undergo external beam radiation therapy,
  • No previous history of nonoral feeding for cancer related illness,
  • Able to undergo MRI procedures.
  • Physician / patient agreement to participate

Exclusion criteria

  • Planned surgical intervention
  • Existence of a co-existing neurological or medical disorder known to cause dysphagia
  • Prior radiotherapy or surgery to the head / neck region that could contribute to dysphagia.
  • Previous swallowing therapy within four weeks of randomization

Treatment and study plan

focused attention sessions

Behavioral

Patient management by the attending Radiation oncologist "as usual". Patients assigned to this condition received focused attention sessions during the total course of their CRT treatment from a Speech Language Pathologist, consisting of weekly phone calls to monitor their swallowing outcome during the radiotherapy period.

Valchuff

Behavioral

Standardised sham or placebo swallowing therapy comprised a buccal extension maneuver ("valchuff") and appropriate dietary modification, under the direction of the study speech pathologist, twice daily each week for the duration of the patient's total course of CRT treatment.

Pharyngocise

Behavioral

Standardized high intensity behavioral swallowing therapy (Pharyngocise) comprised a battery of direct isometric / isotonic exercises and appropriate dietary modification, under the direction of the study speech pathologist, twice daily for the duration of the patient's total course of their CRT treatment (up to a maximum of 6 weeks)

Primary outcomes

  1. Oropharyngeal muscle volume and signal intensity measured by T2 weighted MRI

    Time frame: Baseline, 6 weeks( end of CRT), 6 months(following CRT)

  2. Level of functional swallowing ability- measured by functional eating score (FOIS), clinical swallowing score, videoendoscopy and videofluoroscopic evaluation

    Time frame: Baseline, 6 week(end of CRT), 6 months(following CRT)

  3. Patient perception of swallowing ability

    Time frame: Baseline, 6 weeks (end of CRT), 6 months (following CRT)

  4. Quality of Life

    Time frame: Baseline, 6 weeks (end of CRT), 6 months (following CRT)

Secondary outcomes

  1. Taste perception

    Time frame: Baseline, 6 weeks (end of CRT), 6 months (following CRT)

  2. Perception of smell

    Time frame: Baseline, 6 weeks (end of CRT), 6 months (following CRT)

  3. Salivation rates

    Time frame: Baseline, 6 weeks (end of CRT), 6 months (following CRT)

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Collaborators

  • Florida Department of Health

Registry information

Official study title

Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy: a Randomized Controlled Trial of Swallowing Therapy"

Acronym: Pharyngocise

Important dates

Study start
2001
Primary completion
2004
Study completion
2005
First posted
Nov 24, 2008
Registry last updated
Sep 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.